% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Karpinski:305581,
author = {M. J. Karpinski$^*$ and S. Hoberück and W. P. Fendler$^*$
and C. Civan$^*$ and R. A. Bundschuh and C. Thomas and A.
Bjartell and E. Trägårdh and T. F. W. Soeterik and L.
Evangelista and A. Vondrak and S. Rasul and L. Forner$^*$
and A. D. Giorgio and H. Scholtissek and J. Miksch and A.
Holzgreve and F. Lanfranchi and K. Rahbar and M. S. Hofman
and I. Rauscher and O. Güven and M. Eiber and N. Ayati and
L. Umutlu and K. Herrmann$^*$ and B. Hadaschik$^*$ and L.
Emmett},
title = {{A}ssociation {B}etween the {PRIMARY} {S}core at {S}taging
{P}rostate-specific {M}embrane {A}ntigen {P}ositron
{E}mission {T}omography and {O}verall {S}urvival {A}mong
{P}atients with {N}ewly {D}iagnosed {P}rostate {C}ancer:
{F}indings from the {I}nternational, {M}ulticenter {PROMISE}
{R}egistry.},
journal = {European urology},
volume = {nn},
issn = {0302-2838},
address = {Amsterdam [u.a.]},
publisher = {Elsevier Science},
reportid = {DKFZ-2025-02240},
pages = {nn},
year = {2025},
note = {epub / brief report},
abstract = {The PRIMARY score was implemented in Prostate Cancer
Molecular Imaging Standardized Evaluation (PROMISE) version
2 to improve accuracy for the diagnosis of clinically
significant prostate cancer using prostate-specific membrane
antigen (PSMA) positron emission tomography (PET). We
reviewed overall survival (OS) for patients who underwent
PSMA PET for initial staging to evaluate the prognostic
value of PRIMARY in a large, international, multicenter
cohort. The cohort comprised 1889 patients who underwent
PSMA PET for initial staging of prostate cancer at
investigator sites across Europe and Australia between 2012
and 2021. Hazard ratios (HRs) with $95\%$ confidence
interval (CI) were calculated for PRIMARY scores to identify
predictors of OS. Complete-case head-to-head comparisons
were conducted for Prostate Imaging-Reporting and Data
System (PI-RADS) versus PRIMARY scores, and cT stage versus
PRIMARY scores. We present preliminary findings up to
January 31, 2025, when 231 deaths had occurred. PRIMARY
score 5 (HR 1.5, $95\%$ CI 1.0-2.3; p = 0.045) was
associated with shorter OS. Improvements in C index values
confirmed the added prognostic value of the PRIMARY score
when combined with PI-RADS or cT stage. PRIMARY score 5 on
initial PSMA PET is prognostic for shorter OS. There is
ongoing long-term follow-up in the PROMISE registry
(NCT06320223, promise-pet.org).},
keywords = {Overall survival (Other) / PRIMARY score (Other) / Positron
emission tomography (Other) / Prostate cancer (Other) /
Prostate-specific membrane antigen (Other)},
cin = {ED01},
ddc = {610},
cid = {I:(DE-He78)ED01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41168067},
doi = {10.1016/j.eururo.2025.10.013},
url = {https://inrepo02.dkfz.de/record/305581},
}